Hypoxia induces erythroid-specific 5-aminolevulinate synthase expression in human erythroid cells through transforming growth factor-β signaling

FEBS Journal

Volumn 276, Issue 5, 2009, Pages 1370-1382

  Kaneko, Kiriko ^a   Furuyama, Kazumichi ^a   Aburatani, Hiroyuki ^b   Shibahara, Shigeki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Erythroid specific 5 aminolevulinate synthase; Hemoglobin; Hypoxia; Mitoferrin; Transforming growth factor

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ERYTHROID SPECIFIC 5 AMINOLEVULINATE SYNTHASE; GAMMA GLOBIN; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1; IRON BINDING PROTEIN; MESSENGER RNA; MITOFERRIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CLONAL VARIATION; CULTURE MEDIUM; DNA DETERMINATION; ENZYME INDUCTION; ERYTHROBLAST; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; HYPOXIA; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

5-AMINOLEVULINATE SYNTHETASE; CATION TRANSPORT PROTEINS; CELL DIFFERENTIATION; CELL HYPOXIA; ERYTHROID CELLS; ERYTHROID PRECURSOR CELLS; GAMMA-GLOBINS; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 60349106841     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.06878.x     Document Type: Article

References (50)

1. Ke Q Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70, 1469 1480.
2. Beutler E (2001) Production and destruction of erythrocytes. In Williams Hematology (Beutler E, Lichtman MA, Coller BS, Kipps TJ Seligsohn U, eds pp. 355 368. McGraw-Hill, New York, NY.
3. Friend C, Scher W, Holland JG Sato T (1971) Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci USA 68, 378 382.
4. Harigae H, Suwabe N, Weinstock PH, Nagai M, Fujita H, Yamamoto M Sassa S (1998) Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene. Blood 91, 798 805.
5. Hofer T, Wenger RH, Kramer MF, Ferreira GC Gassmann M (2003) Hypoxic up-regulation of erythroid 5-aminolevulinate synthase. Blood 101, 348 350.
6. Narayan AD, Ersek A, Campbell TA, Colon DM, Pixley JS Zanjani ED (2005) The effect of hypoxia and stem cell source on haemoglobin switching. Br J Haematol 128, 562 570.
7. Endo K, Harigae H, Nagai T, Fujie H, Meguro K, Watanabe N, Furuyama K, Kameoka J, Okuda M, Hayashi N et al. (1993) Two chronic myelogenous leukaemia cell lines which represent different stages of erythroid differentiation. Br J Haematol 85, 653 662.
8. Zhang Y, Furuyama K, Kaneko K, Ding Y, Ogawa K, Yoshizawa M, Kawamura M, Takeda K, Yoshida T Shibahara S (2006) Hypoxia reduces the expression of heme oxygenase-2 in various types of human cell lines. A possible strategy for the maintenance of intracellular heme level. FEBS J 273, 3136 3147.
9. Shibahara S, Yoshizawa M, Suzuki H, Takeda K, Meguro K Endo K (1993) Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation. J Biochem 113, 214 218.
10. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 25 29.
11. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D Siani-Rose MA (2003) NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 31, 82 86.
12. Nagai T, Harigae H, Furuyama K, Munakata H, Hayashi N, Endo K, Sassa S Yamamoto M (1997) 5-Aminolevulinate synthase expression and hemoglobin synthesis in a human myelogenous leukemia cell line. J Biochem 121, 487 495.
13. Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P Orkin SH (1993) Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362, 722 728.
14. Chen JJ (2007) Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood 109, 2693 2699.
15. Evans T Felsenfeld G (1989) The erythroid-specific transcription factor Eryf1: a new finger protein. Cell 58, 877 885.
16. Harigae H (2006) GATA transcription factors and hematological diseases. Tohoku J Exp Med 210, 1 9.
17. Oyake T, Itoh K, Motohashi H, Hayashi N, Hoshino H, Nishizawa M, Yamamoto M Igarashi K (1996) Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol 16, 6083 6095.
18. Suzuki A, Kusakai G, Shimojo Y, Chen J, Ogura T, Kobayashi M Esumi H (2005) Involvement of transforming growth factor-beta 1 signaling in hypoxia-induced tolerance to glucose starvation. J Biol Chem 280, 31557 31563.
19. Warren SM, Steinbrech DS, Mehrara BJ, Saadeh PB, Greenwald JA, Spector JA, Bouletreau PJ Longaker MT (2001) Hypoxia regulates osteoblast gene expression. J Surg Res 99, 147 155.
20. Shaw GC, Cope JJ, Li L, Corson K, Hersey C, Ackermann GE, Gwynn B, Lambert AJ, Wingert RA, Traver D et al. (2006) Mitoferrin is essential for erythroid iron assimilation. Nature 440, 96 100.
21. Furuyama K, Kaneko K Vargas PD (2007) Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis. Tohoku J Exp Med 213, 1 16.
22. Nakajima O, Takahashi S, Harigae H, Furuyama K, Hayashi N, Sassa S Yamamoto M (1999) Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload. EMBO J 18, 6282 6289.
23. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ et al. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468 472.
24. Fink T, Kazlauskas A, Poellinger L, Ebbesen P Zachar V (2002) Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood 99, 2077 2083.
25. Taketani S, Furukawa T Furuyama K (2001) Expression of coproporphyrinogen oxidase and synthesis of hemoglobin in human erythroleukemia K562 cells. Eur J Biochem 268, 1705 1711.
26. Han AP, Yu C, Lu L, Fujiwara Y, Browne C, Chin G, Fleming M, Leboulch P, Orkin SH Chen JJ (2001) Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J 20, 6909 6918.
27. Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67, 753 791.
28. Krystal G, Lam V, Dragowska W, Takahashi C, Appel J, Gontier A, Jenkins A, Lam H, Quon L Lansdorp P (1994) Transforming growth factor beta 1 is an inducer of erythroid differentiation. J Exp Med 180, 851 860.
29. Hooper WC, Pruckler J, Jackson D Evatt BL (1989) Transforming growth factor-beta induces hemoglobin synthesis in a human erythroleukemia cell line. Biochem Biophys Res Commun 165, 145 150.
30. Chen LL, Dean A, Jenkinson T Mendelsohn J (1989) Effect of transforming growth factor-beta 1 on proliferation and induction of hemoglobin accumulation in K-562 cells. Blood 74, 2368 2375.
31. Yu J, Shao LE, Lemas V, Yu AL, Vaughan J, Rivier J Vale W (1987) Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature 330, 765 767.
32. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, Moroney JW, Reed CH, Luban NL, Wang RH et al. (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13, 1096 1101.
33. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S Akhurst RJ (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121, 1845 1854.
34. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ Hill CS (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62, 65 74.
35. Derynck R, Lindquist PB, Lee A, Wen D, Tamm J, Graycar JL, Rhee L, Mason AJ, Miller DA, Coffey RJ et al. (1988) A new type of transforming growth factor-beta, TGF-beta 3. EMBO J 7, 3737 3743.
36. Dunker N Krieglstein K (2000) Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur J Biochem 267, 6982 6988.
37. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N Groffen J (1995) Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11, 415 421.
38. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW Doetschman T (1995) Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 11, 409 414.
39. Ranu RS London IM (1976) Regulation of protein synthesis in rabbit reticulocyte lysates: purification and initial characterization of the cyclic 3′:5′-AMP independent protein kinase of the heme-regulated translational inhibitor. Proc Natl Acad Sci USA 73, 4349 4353.
40. Falanga V, Zhou L Yufit T (2002) Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-beta1. J Cell Physiol 191, 42 50.
41. Lok CN Ponka P (1999) Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 274, 24147 24152.
42. Rogers HM, Yu X, Wen J, Smith R, Fibach E Noguchi CT (2008) Hypoxia alters progression of the erythroid program. Exp Hematol 36, 17 27.
43. Ishikawa Y Ito T (1988) Kinetics of hemopoietic stem cells in a hypoxic culture. Eur J Haematol 40, 126 129.
44. Pennathur-Das R Levitt L (1987) Augmentation of in vitro human marrow erythropoiesis under physiological oxygen tensions is mediated by monocytes and T lymphocytes. Blood 69, 899 907.
45. Allen DW Jandl JH (1960) Factors influencing relative rates of synthesis of adult and fetal hemoglobin in vitro. J Clin Invest 39, 1107 1113.
46. Minegishi N, Minegishi M, Tsuchiya S, Fujie H, Nagai T, Hayashi N, Yamamoto M Konno T (1994) Erythropoietin-dependent induction of hemoglobin synthesis in a cytokine-dependent cell line M-TAT. J Biol Chem 269, 27700 27704.
47. Udono-Fujimori R, Takahashi K, Takeda K, Furuyama K, Kaneko K, Takahashi S, Tamai M Shibahara S (2004) Expression of heme oxygenase-1 is repressed by interferon-gamma and induced by hypoxia in human retinal pigment epithelial cells. Eur J Biochem 271, 3076 3084.
48. Furuyama K, Fujita H, Nagai T, Yomogida K, Munakata H, Kondo M, Kimura A, Kuramoto A, Hayashi N Yamamoto M (1997) Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene. Blood 90, 822 830.
49. Furuyama K Sassa S (2000) Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia. J Clin Invest 105, 757 764.
50. Vargas PD, Furuyama K, Sassa S Shibahara S (2008) Hypoxia decreases the expression of the two enzymes responsible for producing linear and cyclic tetrapyrroles in the heme biosynthetic pathway. FEBS J 275, 5947 5959.